These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26456477)

  • 1. Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.
    Nørgaard M; Cetin K; Maegbaek ML; Kristensen NR; Ghanima W; Bahmanyar S; Stryker S; Christiansen CF
    Br J Haematol; 2016 Aug; 174(4):639-42. PubMed ID: 26456477
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.
    Adelborg K; Kristensen NR; Nørgaard M; Bahmanyar S; Ghanima W; Kilpatrick K; Frederiksen H; Ekstrand C; Sørensen HT; Fynbo Christiansen C
    J Thromb Haemost; 2019 Jun; 17(6):912-924. PubMed ID: 30933417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
    Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
    J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
    Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
    Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
    Severinsen MT; Engebjerg MC; Farkas DK; Jensen AØ; Nørgaard M; Zhao S; Sørensen HT
    Br J Haematol; 2011 Feb; 152(3):360-2. PubMed ID: 20955411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
    Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
    Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in patients with primary chronic immune thrombocytopenia.
    Nørgaard M
    Thromb Res; 2012 Oct; 130 Suppl 1():S74-5. PubMed ID: 23026671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of thrombotic events in patients with immune thrombocytopenia.
    Ito S; Fujiwara SI; Ikeda T; Toda Y; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2020 Jan; 99(1):49-55. PubMed ID: 31853702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is ITP a thrombophilic disorder?
    Rodeghiero F
    Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    Pottegård A; Lund LC; Karlstad Ø; Dahl J; Andersen M; Hallas J; Lidegaard Ø; Tapia G; Gulseth HL; Ruiz PL; Watle SV; Mikkelsen AP; Pedersen L; Sørensen HT; Thomsen RW; Hviid A
    BMJ; 2021 May; 373():n1114. PubMed ID: 33952445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia in patients with chronic immune thrombocytopenia.
    Wong RS; Bakshi K; Brainsky A
    Scand J Clin Lab Invest; 2015 Jan; 75(1):13-7. PubMed ID: 25296772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.
    Zeller B; Rajantie J; Hedlund-Treutiger I; Tedgård U; Wesenberg F; Jonsson OG; Henter JI;
    Acta Paediatr; 2005 Feb; 94(2):178-84. PubMed ID: 15981751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura.
    Tana M; Tana C; Rizzo G; Ricci F; Porreca E
    Eur J Intern Med; 2021 Apr; 86():121-123. PubMed ID: 33568328
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.
    Doobaree IU; Nandigam R; Bennett D; Newland A; Provan D
    Eur J Haematol; 2016 Oct; 97(4):321-30. PubMed ID: 27199203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in immune thrombocytopenia - current status and future perspectives.
    Swan D; Newland A; Rodeghiero F; Thachil J
    Br J Haematol; 2021 Sep; 194(5):822-834. PubMed ID: 33822358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
    Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.
    Diez-Feijóo R; Rodríguez-Sevilla JJ; Colomo L; Papaleo N; Maiques JM; Gimeno E; Andrade-Campos M; Abella E; Merchan BM; Calvo X; Jimenez C; Román-Bravo OD; Salar A; Sanchez-Gonzalez B
    Thromb Res; 2021 Dec; 208():226-229. PubMed ID: 33714615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral venous thrombosis and immune thrombocytopenia in a 7-year-old girl: a fortuitous association?].
    Cotillon M; Lebas A; Blanc T; Schneider P; Vannier JP; Buchbinder N
    Arch Pediatr; 2014 Dec; 21(12):1367-9. PubMed ID: 25445130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
    Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
    Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study.
    Machin N; Ragni MV; Comer DM; Yabes JG
    Thromb Res; 2018 Dec; 172():80-85. PubMed ID: 30384039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.